Siemens Healthineers Q2 Profit Rises; Lifts FY Outlook

Siemens Healthineers AG (SMMNY.PK) reported that its second-quarter net income rose to 443 million euros from 411 million euros last year. On a per share, earnings for the quarter was 0.41 euros, unchanged from last year.

Adjusted basic earnings per share declined five percent to 0.44 euros, mainly due to an eight percent increase in the weighted average number of outstanding shares resulting from the issuance of new shares in connection with the financing of the Varian acquisition. Currency effects also had a negative effect.

Revenue for the quarter grew to 3.97 billion euros from 3.69 billion euros in the previous year.

Looking ahead for 2021, the company expects comparable revenue growth between 14% and 17% from fiscal year 2020 compared to the prior outlook of 8% to 12% growth.

The company expects annual adjusted basic earnings per share to be between 1.90 euros and 2.05 euros compared to the prior outlook of 1.63 euros to 1.82 euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets. Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million. The acquisition further accelerates Elanco's...
Follow RTT